Franklin Biotechnology Discovery Fund A-H1 Fonds
14,28
CHF
-0,21
CHF
-1,45
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 7,80% |
| Gilead Sciences Inc | US3755581036 | 7,69% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,56% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,34% |
| Ascendis Pharma AS ADR | US04351P1012 | 4,35% |
| Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | 4,04% |
| argenx SE ADR | US04016X1019 | 3,73% |
| PTC Therapeutics Inc | US69366J2006 | 2,97% |
| Merus NV | NL0011606264 | 2,86% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,50% |
| Sonstige | 51,17% |